Monday, August 01, 2022 12:37:22 PM
In searching for information regarding cancer treatment costs, todays expected costs are $150k up to $500k. Some of these treatments do not overlap with Radiogel, but some do. Let's go low at $150k.
Brachytherapy treatment - with much better and faster results in some cases - is only a fraction of that at, from what I have read, about $10k per treatment with say up to two treatments. This explains a lot to me, like why a big pharma would stay clear of this since it can and will, eat into their massive profits. Sounds like this will take an outsider to develop this product.
I deleted my FDA delay conspiracy theory from this.
I see it will be a game changer for treatment and cancer drug treatment companies, as well as a more affordable option for EVERYONE. I would guess the Dr. Mike would even provide low cost treatment alternatives to those in need.
This will be worldwide and If the US government latches on to this as treatment due to its cost savings, that would be immense.
Game changer may be an understatement.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940781/
Recent RDGL News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:40:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 12/07/2023 05:15:10 AM
- Form 1-A POS - • Edgar (US Regulatory) • 11/27/2023 10:29:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 04:28:46 PM
- Form 1-A POS - • Edgar (US Regulatory) • 11/03/2023 09:03:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 04:18:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 10:33:58 AM
- Form 1-A POS - • Edgar (US Regulatory) • 10/10/2023 04:05:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 07:22:21 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM